Gene Expression Mediated Antiproliferative Potential and Safety of Selected Medicinal Plants Against Cancerous and Normal Cells
AbstractGlobally, approximately 13% of all deaths annually are attributed to cancer. Surgery, radiation and chemotherapy are the current treatment techniques for cancer, however these methods are expensive, have high failure rates and have been associated with detrimental side effects. Plant derived products could be good candidates in alleviating challenges being experienced with these current methods. This study aimed at evaluating the phytochemistry, antiproliferation potential, and probable mechanism of action ofAlbizia gummifera,Rhamnus staddoandSenna didymobotryaplant extracts. Phytochemical screening was done as per standard procedures. The common 3– (4, 5-dimethylthiazol-2-yl) -2, 5-diphenyltetrazolium (MTT) dye was used in the determination of the antiproliferative activity of the extracts. Extracts induction ofVEGF(angiogenesis) and p53 (apoptosis) genes’ expression was evaluated using Real Time Polymerase Chain Reaction. Phytochemical screening revealed presence of alkaloids, tannins, glycosides, flavonoids, terpenes, phenolics and saponins in the plants extracts.A. gummifera’sstem bark methanol: dichloromethane extract had the highest activity against the cancerous cell lines tested: HCC1395 (IC506.07±0.04μg/ml), DU145 (IC503.34±0.05μg/ml), CT26 (IC505.78±0.08μg/ml) and Hep2 (IC507.02±0.01μg/ml).R. staddoroot bark methanol: dichloromethane extract had an IC50value of 15.71±0.04μg/ml on HCC, 9.81±0.09μg/ml on Hep2 and 11.14±0.39μg/ml on CT26.S. didymobotryaroot bark methanol: dichloromethane extract inhibited HCC with an IC50of 65.06±0.07μg/ml, CT26 with an IC50of 15.71±0.04μg/ml and Hep2 with an IC50of 62.10±0.11μg/ml. From the results obtained, the plants exhibited selective toxicity to cancer cells while sparing the normal cells (SI ≥ 3).A. gummiferaandS. didymobotryaandR. staddoplant extracts upregulated p53 and down-regulatedVEGFgenes. In conclusion, this study confirms that these plant extracts could be potential candidates for development of drugs for the management of breast, prostrate, colorectal and throat cancer.